Status:
RECRUITING
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
Lead Sponsor:
Yale University
Conditions:
Prostate Cancer
Eligibility:
MALE
18-80 years
Brief Summary
The investigators hypothesize that this single-cell analysis can be used to evaluate prostate needle-core biopsies prospectively even in non-homogenous samples by providing profiles of proteomic and p...
Detailed Description
Current approaches for early detection and diagnosis include prostate-specific antigen (PSA) which is a useful, though not specific, biomarker for detecting prostate cancer. The suspected patients wil...
Eligibility Criteria
Inclusion
- Only subjects that have scheduled Artemis prostate biopsy with defined regions of interest will be included in this study
Exclusion
- Any subjects that are unable to provide informed consent will be excluded
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT02313623
Start Date
July 1 2013
End Date
October 1 2025
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University
New Haven, Connecticut, United States, 06520